Indeed, the benefits of mTOR inhibition have been demonstrated in the clinical treatment of breast cancer (Baselga et al., 2012; Basho et al., 2018), indicating the centrality of this anabolic master switch for the both the prevention and combatting of cancer. This evidence concerns the gene MTOR and breast carcinoma.